Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Egr-3 Inhibitors

Egr-3 inhibitors, short for Early Growth Response 3 inhibitors, belong to a specific chemical class of compounds designed to modulate the activity of the transcription factor Egr-3. Transcription factors are proteins that play a pivotal role in regulating gene expression, and Egr-3 is a member of the Egr family known for its involvement in cellular responses to various stimuli, including stress, growth factors, and cytokines. Egr-3, in particular, is a zinc finger transcription factor that is implicated in the control of several important biological processes, such as cell proliferation, differentiation, and apoptosis. The development of Egr-3 inhibitors represents a targeted approach to manipulate these cellular processes by regulating the activity of Egr-3. The chemical structures of Egr-3 inhibitors are designed to interact specifically with Egr-3 or its associated proteins, thereby interfering with its ability to bind to DNA and initiate the transcription of target genes. This inhibition impact various cellular pathways, depending on the specific genes regulated by Egr-3. Egr-3 inhibitors are often utilized in laboratory research to better understand the molecular mechanisms underlying Egr-3's functions. By inhibiting Egr-3 activity, these inhibitors provide valuable insights into the intricate network of gene regulation and cellular responses, shedding light on how manipulating transcription factors like Egr-3 can influence diverse physiological processes.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid receptor agonist that can suppress the expression of Egr-3 by affecting inflammatory signaling pathways.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Influences glycogen synthase kinase-3 (GSK-3) activity, which indirectly affects the signaling pathways that regulate Egr-3 transcription.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAP kinase inhibitor that may reduce Egr-3 expression by blocking the kinase activity that is required for its transcriptional activation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can block the ERK pathway, subsequently downregulating the activity of Egr-3 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which can attenuate the signaling required for the induction of Egr-3 expression in response to stress.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that may reduce Egr-3 expression by altering the PI3K/Akt signaling pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

By inhibiting MEK1/2, this compound can decrease ERK pathway signaling and consequently lower Egr-3 expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

As a PI3K inhibitor, it can indirectly suppress Egr-3 expression by impacting downstream signaling pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor which may downregulate Egr-3 expression by interfering with growth factor signaling.

1-β-D-Arabinofuranosylcytosine

147-94-4sc-201628
sc-201628A
sc-201628B
sc-201628C
sc-201628D
1 g
5 g
25 g
100 g
250 g
$150.00
$263.00
$518.00
$731.00
$1461.00
1
(1)

A nucleoside metabolic inhibitor that can decrease Egr-3 expression by interrupting DNA synthesis.